Pioneering hematologist J. Evan Sadler, MD, PhD, a world-renowned expert in the study and treatment of blood clotting disorders and director of the Division of Hematology at Washington University School of Medicine in St. Louis, has made significant contributions to the field of hematology. Sadler's research has focused on the molecular mechanisms that underlie blood clotting and the development of new treatments for clotting disorders.
Sadler's interest in hematology began early in his career when he was a medical student at Duke University. He was fascinated by the complex mechanisms that regulate blood clotting and decided to pursue a career in hematology. After completing his medical degree, Sadler went on to earn a PhD in biochemistry from Duke University and completed his residency in internal medicine at Duke University Medical Center.
Sadler's research has focused on understanding the molecular mechanisms that regulate blood clotting and the role of clotting disorders in disease. He has made significant contributions to the development of new treatments for hemophilia, a rare blood disorder that affects the ability of the blood to clot properly.